# NWBO (Northwest Biotherapeutics Inc.) - SEC EDGAR Financial Statements

> Northwest Biotherapeutics Inc. reported $2.86M in revenue and a net loss of $39.66M for the trailing twelve months ended September 30, 2026 (up 341.5% year over year), with a -1608.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/NWBO
- Markdown: https://convexityos.com/fundamentals/NWBO.md
- SEC CIK: 0001072379
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:41 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001072379&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.86M | +341.5% YoY |
| Operating Income | TTM | -$45.95M | -1608.8% margin |
| Net Income | TTM | -$39.66M | -1388.8% net margin |
| Diluted EPS | TTM | -$0.02 | Split-adjusted |
| Free Cash Flow | TTM | -$44.48M | -1557.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $725K | Total debt: $69.83M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.38M | $1.38M | $1.93M | $1.68M | $1.00M | $1.29M | $2.41M | $412K | $336K | $623K |
| Research & Development | $28.79M | $34.89M | $27.73M | $35.51M | $20.31M | $33.64M | $14.11M | $18.15M | $33.52M | $60.08M |
| **Operating Income** | -$59.91M | -$66.51M | -$55.51M | -$67.18M | -$52.70M | -$86.61M | -$27.98M | -$41.48M | -$54.68M | -$79.27M |
| **EBITDA** | -$57.85M | -$64.76M | -$53.98M | -$65.93M | -$52.38M | -$86.52M | -$27.96M | -$40.19M | -$54.24M | -$79.08M |
| Interest Expense | $8.70M | $7.77M | $5.24M | $6.07M | $5.01M | $8.54M | $2.98M | $9.87M | $5.54M | $3.82M |
| Income Before Tax | -$60.70M | -$83.78M | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | -$537K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$60.16M | -$83.78M | -$62.60M | -$105.0M | $179.1M | -$529.8M | -$20.81M | -$35.79M | -$73.14M | -$80.21M |
| Basic EPS | -$0.04 | -$0.07 | -$0.06 | -$0.10 | $0.21 | -$0.73 | -$0.04 | -$0.12 | -$0.31 | -$0.77 |
| **Diluted EPS** | -$0.04 | -$0.07 | -$0.06 | -$0.10 | -$0.06 | -$0.73 | -$0.04 | -$0.12 | -$0.31 | -$0.77 |
| Basic Shares Outstanding | 1.46B | 1.24B | 1.1M | 1.0M | 873.5K | 725.1K | 564.2K | 440.0M | 242.8M | 111.1M |
| Diluted Shares Outstanding | 1.46B | 1.24B | 1.1M | 1.0M | 1.0M | 725.1K | 564.2K | 440.0M | 242.8M | 111.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $883K | $807K | $494K | $672K | $200K | $131K | $375K | $231K |
| Research & Development | $4.22M | $5.71M | $4.86M | $5.55M | $7.45M | $7.43M | $8.35M | $10.52M |
| **Operating Income** | -$9.94M | -$11.61M | -$10.90M | -$13.50M | -$14.32M | -$14.78M | -$17.31M | -$18.50M |
| **EBITDA** | -$9.15M | -$10.83M | -$10.13M | -$12.78M | -$13.92M | -$14.28M | -$16.91M | -$18.06M |
| Interest Expense | $2.60M | $1.81M | $2.35M | $2.65M | $2.62M | $1.83M | $1.60M | $2.49M |
| **Net Income** | -$28.76M | -$9.22M | -$3.07M | $1.39M | -$26.83M | -$15.38M | -$19.34M | -$28.22M |
| Basic EPS | -$0.02 | -$0.01 | $0.00 | -- | -$0.02 | -$0.01 | -$0.01 | -- |
| **Diluted EPS** | -$0.02 | -$0.01 | $0.00 | -- | -$0.02 | -$0.01 | -$0.01 | -- |
| Basic Shares Outstanding | 1.71B | 1.64B | 1.58B | -- | 1.49B | 1.44B | 1.36B | -- |
| Diluted Shares Outstanding | 1.71B | 1.64B | 1.58B | -- | 1.49B | 1.44B | 1.36B | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.04M | $2.17M | $2.13M | $6.96M | $15.17M | $9.98M | $372K | $22.22M | $117K | $6.87M |
| **Cash & Short-Term Investments** | $3.04M | $2.17M | $2.13M | $6.96M | $15.17M | $9.98M | $372K | $22.22M | $117K | $6.87M |
| **Total Current Assets** | $5.52M | $4.06M | $4.12M | $9.43M | $17.29M | $15.51M | $3.20M | $23.80M | $1.40M | $7.88M |
| Property, Plant & Equipment, Net | $17.41M | $16.20M | $17.28M | $13.42M | $15.03M | $1.04M | $281K | $108K | $47.49M | $315K |
| Goodwill | $626K | $626K | $626K | $626K | $626K | $626K | $0 | -- | -- | -- |
| Intangible Assets | $53.19M | $1.29M | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $356K | $365K | $361K | $345K | $1.04M | $867K | $798K | $761K | $17K | $148K |
| **Total Non-Current Assets** | $75.77M | $22.67M | $23.74M | $21.90M | $22.87M | $17.39M | $7.44M | $869K | $47.51M | $45.02M |
| **Total Assets** | $81.29M | $26.73M | $27.86M | $31.32M | $40.16M | $32.90M | $10.64M | $24.67M | $48.91M | $52.91M |
| Accounts Payable | -- | -- | -- | -- | -- | -- | -- | -- | -- | $12.38M |
| Other Current Liabilities | $8.35M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $91.70M | $68.27M | $45.20M | $126.0M | $133.8M | $382.4M | $44.20M | $69.84M | $87.68M | $76.41M |
| Long-Term Debt | $60.04M | $62.68M | $40.79M | $21.53M | $32.40M | $14.77M | $12.72M | $16.80M | $31.43M | $31.71M |
| **Total Non-Current Liabilities** | $37.16M | $37.43M | $29.72M | $10.36M | $30.38M | $13.42M | $11.50M | $1.99M | $8.52M | $3.00M |
| **Total Liabilities** | $128.9M | $105.7M | $74.92M | $136.4M | $164.2M | $395.8M | $55.70M | $71.83M | $96.20M | $79.41M |
| **Total Debt (incl. Leases)** | $64.83M | $67.44M | $45.56M | $26.25M | $37.94M | $19.86M | $18.03M | $16.80M | $31.43M | $31.71M |
| Common Stock | $1.57M | $1.33M | $1.18M | $1.07M | $948K | $830K | $614K | $523K | $329K | $157K |
| Retained Earnings | -$1.50B | -$1.44B | -$1.36B | -$1.30B | -$1.19B | -$1.37B | -$841.4M | -$824.4M | -$788.6M | -- |
| Accumulated Other Comp. Income | -$925K | $3.04M | $1.54M | $3.15M | $357K | -$1.15M | $836K | $1.00M | -$597K | $1.85M |
| **Total Stockholders' Equity** | -$60.28M | -$94.49M | -$65.77M | -$128.1M | -$124.0M | -$362.9M | -$45.05M | -$48.13M | -$67.33M | -$26.50M |
| Total Equity | -$60.28M | -$94.49M | -$65.77M | -$128.1M | -$124.0M | -$362.9M | -$45.05M | -$48.13M | -$67.33M | -$26.50M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $725K | $595K | $1.79M | $3.04M | $4.56M | $4.32M | $2.78M | $2.17M |
| **Cash & Short-Term Investments** | $725K | $595K | $1.79M | $3.04M | $4.56M | $4.32M | $2.78M | $2.17M |
| **Total Current Assets** | $2.43M | $2.57M | $6.20M | $5.52M | $7.20M | $6.16M | $4.69M | $4.06M |
| Property, Plant & Equipment, Net | $16.07M | $16.48M | $16.77M | $17.41M | $16.87M | $16.68M | $16.29M | $16.20M |
| Goodwill | $626K | $626K | $626K | $626K | $626K | $626K | $626K | $626K |
| Intangible Assets | $51.78M | $51.93M | $52.05M | $53.19M | -- | -- | -- | $1.29M |
| Other Non-Current Assets | $378K | $354K | $354K | $356K | $358K | $370K | $367K | $365K |
| **Total Non-Current Assets** | $73.71M | $73.37M | $73.85M | $75.77M | $23.41M | $23.39M | $22.82M | $22.67M |
| **Total Assets** | $76.14M | $75.94M | $80.05M | $81.29M | $30.61M | $29.55M | $27.50M | $26.73M |
| Other Current Liabilities | $6.32M | $6.66M | $7.32M | $8.35M | -- | -- | -- | -- |
| **Total Current Liabilities** | $90.94M | $73.35M | $82.97M | $91.70M | $87.91M | $83.92M | $83.06M | $68.27M |
| Long-Term Debt | $64.51M | $51.97M | $59.43M | $60.04M | $72.20M | $64.74M | $64.14M | $62.68M |
| **Total Non-Current Liabilities** | $31.50M | $37.37M | $35.14M | $37.16M | $37.95M | $32.26M | $29.28M | $37.43M |
| **Total Liabilities** | $122.4M | $110.7M | $118.1M | $128.9M | $125.9M | $116.2M | $112.3M | $105.7M |
| **Total Debt (incl. Leases)** | $69.83M | $56.44M | $63.99M | $64.83M | $77.05M | $69.81M | $69.00M | $67.44M |
| Common Stock | $1.77M | $1.68M | $1.62M | $1.57M | $1.52M | $1.46M | $1.39M | $1.33M |
| Retained Earnings | -$1.54B | -$1.52B | -$1.51B | -$1.50B | -$1.51B | -$1.48B | -$1.46B | -$1.44B |
| Accumulated Other Comp. Income | -$107K | -$246K | -$429K | -$925K | -$1.22M | -$1.85M | $1.40M | $3.04M |
| **Total Stockholders' Equity** | -$56.70M | -$45.17M | -$50.54M | -$60.28M | -$108.6M | -$100.4M | -$99.48M | -$94.49M |
| Total Equity | -$56.70M | -$45.17M | -$50.54M | -$60.28M | -$108.6M | -$100.4M | -$99.48M | -$94.49M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$60.20M | -$83.80M | -$62.80M | -$105.0M | $179.1M | -$529.8M | -$20.81M | -$35.79M | -$73.14M | -$80.21M |
| Depreciation & Amortization | $2.06M | $1.74M | $1.52M | $1.25M | $324K | $87K | $21K | $1.29M | $439K | $189K |
| Stock-Based Compensation | $1.21M | $3.46M | $3.60M | $12.30M | $15.57M | $51.95M | $1.82M | $14.29M | $842K | $127K |
| **Operating Cash Flow** | -$44.76M | -$57.02M | -$53.64M | -$52.77M | -$38.30M | -$32.09M | -$31.86M | -$34.59M | -$36.49M | -$55.65M |
| Capital Expenditure | -$1.50M | -$1.01M | -$3.44M | -$2.90M | -$6.01M | -$6.61M | -$171K | $0 | -- | -- |
| **Free Cash Flow** | -$46.27M | -$58.03M | -$57.07M | -$55.68M | -$44.31M | -$38.70M | -$32.03M | -$34.59M | -- | -- |
| Acquisitions, Net | -- | -- | -- | -- | -- | -$1.53M | -- | -- | -- | -- |
| **Investing Cash Flow** | -$1.81M | -$1.01M | -$3.44M | -$2.90M | -$6.01M | -$8.14M | -$360K | $45.40M | $212K | -$4.94M |
| Common Stock Issued | $19.32M | $14.22M | -- | -- | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $49.33M | $56.78M | $52.76M | $41.97M | $48.13M | $52.70M | $9.95M | $7.87M | $34.29M | $38.31M |
| **Net Change in Cash** | $865K | $49K | -$4.84M | -$8.20M | $5.19M | $9.61M | -$21.85M | $22.11M | -$6.75M | -$16.18M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$28.80M | -$15.40M | $3.10M | -$121.8M | $96.30M | -$15.40M | -$19.30M | -$28.20M |
| Depreciation & Amortization | $792K | $774K | $771K | $728K | $400K | $500K | $400K | $437K |
| Stock-Based Compensation | $148K | $181K | $288K | $185K | $273K | $364K | $385K | $476K |
| **Operating Cash Flow** | -$8.76M | -$7.17M | -$12.51M | -$14.76M | -$13.89M | -$6.69M | -$9.42M | -$20.18M |
| Capital Expenditure | -$53K | -$198K | -$129K | -$905K | -$202K | -$304K | -$93K | -$78K |
| **Free Cash Flow** | -$8.81M | -$7.37M | -$12.64M | -$15.67M | -$14.10M | -$6.99M | -$9.51M | -$20.26M |
| **Investing Cash Flow** | -$53K | -$198K | -$129K | -$905K | -$513K | -$304K | -$93K | -$78K |
| Common Stock Issued | $0 | $104K | $2.90M | $2.02M | $4.86M | $7.32M | $5.12M | -- |
| **Financing Cash Flow** | $8.63M | $7.37M | $9.21M | $13.59M | $11.56M | $12.45M | $11.73M | $15.94M |
| **Net Change in Cash** | $130K | -$1.19M | -$1.25M | -$1.52M | $244K | $1.54M | $604K | -$764K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -4347.9% | -4812.4% | -2873.1% | -3991.7% | -5244.0% | -6708.4% | -1161.0% | -10068.2% | -16273.2% | -12723.3% |
| **Net Profit Margin** | -4365.9% | -6062.1% | -3240.1% | -6240.8% | 17823.5% | -41039.6% | -863.6% | -8687.9% | -21768.8% | -12875.4% |
| Return on Assets (ROA) | -74.0% | -313.4% | -224.7% | -335.3% | 446.0% | -1610.4% | -195.5% | -145.1% | -149.6% | -151.6% |
| Current Ratio | 0.06x | 0.06x | 0.09x | 0.07x | 0.13x | 0.04x | 0.07x | 0.34x | 0.02x | 0.10x |
| Quick Ratio | 0.03x | 0.03x | 0.05x | 0.06x | 0.11x | 0.03x | 0.01x | 0.32x | 0.00x | 0.09x |
| **Revenue Growth (YoY)** | -0.3% | -28.5% | +14.8% | +67.5% | -22.2% | -46.4% | +485.0% | +22.6% | -46.1% | -64.2% |
| **Net Income Growth (YoY)** | -- | -- | -- | -158.6% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -147.6% | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -99.9% | -100.0% | +184263.2% | +119643.2% | +20413.3% | +7856.2% | +17306.1% | -96.2% | -100.0% | +5183.2% |
| 10Y Revenue / Share Growth | -95.8% | -95.5% | +6912.7% | -97.5% | +1083656.6% | +1193871.5% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1608.8% | -2316.1% | -3574.0% | -4347.9% | -6927.3% | -5977.1% | -4621.5% | -4812.4% |
| **Net Profit Margin** | -1388.8% | -1736.4% | -2931.7% | -4365.9% | -9580.9% | -7524.5% | -5757.6% | -6062.1% |
| Return on Assets (ROA) | -52.1% | -49.7% | -54.8% | -74.0% | -293.3% | -278.6% | -308.3% | -313.4% |
| Current Ratio | 0.03x | 0.04x | 0.07x | 0.06x | 0.08x | 0.07x | 0.06x | 0.06x |
| Quick Ratio | 0.01x | 0.01x | 0.02x | 0.03x | 0.05x | 0.05x | 0.03x | 0.03x |
| **Revenue Growth (YoY)** | +341.5% | +516.0% | +31.7% | +190.9% | -44.0% | -74.3% | +32.0% | -48.1% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
